Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00414037 · ClinicalTrials.gov registry record · Phase 4

How do Sleeping Pills Affect Pain in the Brain?

A Phase 4 study, sponsored by University of California, San Diego.

Terminated
Registry status
Phase 4
Development phase
40
Enrollment target

NCT00414037 is a Phase 4 study that was terminated before completion, run by University of California, San Diego. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00414037, a Phase 4 study, was terminated before completion, sponsored by University of California, San Diego.

TERMINATED
Registry status
Phase 4
Development phase
40 participants
Enrollment target

Study Summary

If you are age 20-55 years old and have trouble falling or staying asleep, then please contact a UCSD research team to find out how a study drug affects these symptoms and how your brain works. This is a one-week experimental pain research study using a study drug compared to placebo. Your participation will include questionnaires, a physical exam and functional Magnetic Resonance Imaging (fMRI) brain imaging techniques. We will test pain perception by applying brief mild to moderate heat pain to the forearm, and also have you perform simple computer tasks while we image and record brain activity using fMRI.

Interventions

  • DRUG Placebo
  • DRUG Eszopiclone

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2006-12
Est. Completion 2008-12
Phase Phase 4

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT00414037

The ClinicalTrials.gov registry entry for NCT00414037 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT00414037 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00414037 about?

NCT00414037 is a clinical study titled "How do Sleeping Pills Affect Pain in the Brain?". If you are age 20-55 years old and have trouble falling or staying asleep, then please contact a UCSD research team to find out how a study drug affects these symptoms and how your brain works. This is a one-week experimental pain research study using a study drug compared to placebo. Your participa...

What is the current status of trial NCT00414037?

This trial is currently terminated. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2006-12. Estimated completion is 2008-12.

What interventions are being tested in trial NCT00414037?

The interventions under investigation include: Placebo (DRUG), Eszopiclone (DRUG).

Who is sponsoring clinical trial NCT00414037?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.